- Home
- NBIX vs CPT Comparison
NBIX vs CPT Comparison
Compare NBIX & CPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIX
- CPT
- Stock Information
- Founded
- NBIX 1992
- CPT 1993
- Country
- NBIX United States
- CPT United States
- Employees
- NBIX N/A
- CPT N/A
- Industry
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- CPT Real Estate Investment Trusts
- Sector
- NBIX Health Care
- CPT Real Estate
- Exchange
- NBIX Nasdaq
- CPT Nasdaq
- Market Cap
- NBIX 14.4B
- CPT 11.6B
- IPO Year
- NBIX 1996
- CPT 1993
- Fundamental
- Price
- NBIX $136.19
- CPT $102.90
- Analyst Decision
- NBIX Strong Buy
- CPT Buy
- Analyst Count
- NBIX 17
- CPT 18
- Target Price
- NBIX $163.71
- CPT $123.10
- AVG Volume (30 Days)
- NBIX 895.4K
- CPT 823.8K
- Earning Date
- NBIX 10-29-2025
- CPT 10-30-2025
- Dividend Yield
- NBIX N/A
- CPT 4.06%
- EPS Growth
- NBIX 2.97
- CPT N/A
- EPS
- NBIX 3.39
- CPT 1.43
- Revenue
- NBIX $2,509,900,000.00
- CPT $1,570,124,000.00
- Revenue This Year
- NBIX $20.75
- CPT $2.74
- Revenue Next Year
- NBIX $14.73
- CPT $2.75
- P/E Ratio
- NBIX $40.40
- CPT $72.19
- Revenue Growth
- NBIX 18.42
- CPT 0.75
- 52 Week Low
- NBIX $84.23
- CPT $102.35
- 52 Week High
- NBIX $154.61
- CPT $127.65
- Technical
- Relative Strength Index (RSI)
- NBIX 45.70
- CPT 32.76
- Support Level
- NBIX $135.59
- CPT $105.02
- Resistance Level
- NBIX $148.00
- CPT $107.11
- Average True Range (ATR)
- NBIX 3.15
- CPT 1.58
- MACD
- NBIX -1.16
- CPT -0.44
- Stochastic Oscillator
- NBIX 6.69
- CPT 8.35
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About CPT Camden Property Trust
Camden Property Trust is a real estate investment trust engaged in the ownership, management, development, reposition, redevelopment, acquisition, and construction of multifamily apartment communities. It owned interests in, operated, or developing nearly 177 multifamily properties comprised of nearly 59,996 apartment homes across the United States.